Modeling pro-death signaling pathways in cancer hepatocytes using multi-combinatorial treatments of inhibitors and stimuli

Cell death in hepatocellular carcinoma (HCC) cells as well as in other cell types is driven by a complex signaling transduction network comprised of several different pathways. In this study, we measured cell death of the HCC cell line C3A and we quantify the contribution of several signaling pathways using a reverse approach; namely instead of measuring the activity of the intracellular signal, we correlated the inhibition of that signal to the cell death. To achieve that, cells were treated with 6 stimuli and 7 inhibitors in a multi-combinatorial manner. Approximately 400 observations were made with the simultaneous treatment of up to 2 inhibitors with up to 3 stimuli. A modified linear regression model was developed to predict cell death as indicated by lactate dehydrogenase (LDH) activity. The correlation coefficients of this model were used to quantify the role of each pathway on HCC cell death. Our results are in good agreement with the literature; caspase 8 was revealed as the strongest pro-death mediator whereas the Akt pathway was shown to be the most pro-survival signal. MEK/ERK pathway had a dual role depending on the applied stimuli. Experimentally, the present method is fast, cost efficient, and easy. The coupling of the experiments to a mathematical model allowed us to quantify the contributions of a broad spectrum of pathways on cellular behavior. Additionally, such approach has a significant advantage in cases where measurements of signaling activities (i.e. from cell lysates) are experimentally impractical. For example, using the current methodology we might be able to monitor chondrocyte signaling transduction within its native environment: the articular cartilage extracellular matrix which presents a major challenge in cartilage biology.

[1]  J. Deschner,et al.  Role of NF-kappaB transcription factors in antiinflammatory and proinflammatory actions of mechanical signals. , 2004, Arthritis and rheumatism.

[2]  Xiao-Ming Yin,et al.  Death receptor activation-induced hepatocyte apoptosis and liver injury. , 2003, Current molecular medicine.

[3]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[4]  G. Gores,et al.  Apoptosis and necrosis in the liver: A tale of two deaths? , 2006, Hepatology.

[5]  Z. Tian,et al.  Growth inhibition of human hepatocellular carcinoma cells by blocking STAT3 activation with decoy-ODN. , 2008, Cancer letters.

[6]  Frank Staib,et al.  Genetics of hepatocellular carcinoma. , 2007, World journal of gastroenterology.

[7]  T. Luedde,et al.  Intracellular survival pathways in the liver , 2006, Liver international : official journal of the International Association for the Study of the Liver.

[8]  I. Ng,et al.  Molecular Pathogenesis of Hepatocellular Carcinoma , 2016, Liver Cancer.

[9]  D. Brenner,et al.  NF-kappaB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis. , 2001, Gastroenterology.

[10]  H. Huynh,et al.  Targeted inhibition of the extracellular signal-regulated kinase kinase pathway with AZD6244 (ARRY-142886) in the treatment of hepatocellular carcinoma , 2007, Molecular Cancer Therapeutics.

[11]  I. Fabregat,et al.  Survival and apoptosis: a dysregulated balance in liver cancer , 2007, Liver international : official journal of the International Association for the Study of the Liver.

[12]  J. Avruch,et al.  Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. , 2001, Physiological reviews.

[13]  D. Brenner,et al.  NF-κB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-α– and Fas-mediated apoptosis , 2001 .

[14]  P. Ind,et al.  Concentration effect relationships of infused histamine in normal volunteers , 1982, Agents and Actions.

[15]  J. Sebolt-Leopold,et al.  Targeting MEK is Effective Chemoprevention of Hepatocellular Carcinoma in TGF-α-Transgenic Mice , 2007, Journal of Gastrointestinal Surgery.

[16]  W. Thasler,et al.  P60-c-src suppresses apoptosis through inhibition of caspase 8 activation in hepatoma cells, but not in primary hepatocytes. , 2007, Journal of hepatology.

[17]  S. Thorgeirsson,et al.  Molecular pathogenesis of human hepatocellular carcinoma , 2002, Nature Genetics.

[18]  D. Bader,et al.  Signal transduction pathways involving p38 MAPK, JNK, NFκB and AP-1 influences the response of chondrocytes cultured in agarose constructs to IL-1β and dynamic compression , 2008, Inflammation Research.